Rare Cannabinoids News Today

The wide range of cannabinoids offers opportunities for researchers to better understand their potential future uses.

At the last Benzinga Cannabis Capital Conference, industry experts discussed the rising demand for rare cannabinoids, which are lesser-known compounds found in the cannabis plant known for their unique therapeutic properties.

Radicle Science, an AI-driven healthtech B-corp pioneering large scale clinical trials on health and wellness products, today announced the results of history’s largest cannabinoid clinical trial on pain, in partnership with Open Book Extracts (OBX). All formulations in the pain study on Cannabidiol (CBD) and Rare Cannabinoids were supplied by OBX, a NSF-certified manufacturer andRadicle Science, an AI-driven healthtech B-corp pioneering large scale clinical trials on health and wellness produ...

/PRNewswire/ -- Radicle Science, an AI-driven healthtech B-corp pioneering large scale clinical trials on health and wellness products, today announced the...

Accredited Investor email list Some investment opportunities are limited to accredited investors. Whether you are an accredited investor or not depends on where you live and other criteria. For full details go to https://investingnews.com/accredited-investor-definition/ or search for "accredited investor" in the search bar above. By completing this form, you are giving consent to receive communication from Hempsana using the contact information you provide. And remember you can unsubscri...

Analysis of Cross Sector Adoption and Ancillary Business Capabilities of Cannabinoids, 2020 Report News provided by Share this article Share this article ResearchAndMarkets.coms offering. Cannabinoids as an ingredient for use in pharmaceuticals, F&B, and other industries are steadily gaining in interest across the globe, While R&D and technology developments are on the rise, the industry is still emerging considering the regulatory scenario and the technology limitations. With many technology ...